checkAd

     141  0 Kommentare Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials - Seite 2

    “At The Mended Hearts, Inc. we are committed to fostering a community of support and empowerment for individuals and caregivers navigating heart disease by providing them with compassion, education and resources,” said Denise Duch Widzgowski, President and Chair of the Board of The Mended Hearts, Inc. “By joining forces with WomenHeart, and thanks to the support of Cytokinetics, we can extend our reach and the informational resources we provide to assist patients in navigating the complexities of the clinical trial landscape.”

    “We take great pride in collaborating with The Mended Hearts, Inc. to bring forward the ENACT initiative to cardiovascular patients in need, and express our gratitude to Cytokinetics for helping launch this initiative,” said Celina Gorre, CEO of WomenHeart. “Women have historically been underrepresented in clinical research, which can limit our understanding of how certain treatments may affect them differently than men. As an organization serving women with heart disease, we hope that by encouraging more women to participate in clinical trials, we can help advance cardiovascular care and at the same time promote equity in clinical research.”

    About The Mended Hearts, Inc.

    Lesen Sie auch

    The Mended Hearts, Inc. (MHI) is the world’s largest peer-to-peer cardiovascular patient support network with nearly 100,000 members residing in 20 countries. Founded in 1951 and incorporated in 1955, MHI’s mission is “to inspire hope and improve the quality of life of heart patients and their families through ongoing peer-to-peer support, education, and advocacy.” For nearly 72 years, MHI has been offering hope, support, and encouragement to patients and families of all ages – from pre-natal diagnosis throughout the lifespan. MHI’s three programs — Mended Little Hearts, Young Mended Hearts, and Mended Hearts — make MHI the only organization in the world that supports patients with all forms of cardiovascular disease throughout the entire lifespan of the patient. MHI volunteers inspire, educate, and empower nearly 400,000 patients and family members each year through a robust network of members who provide services and outreach in hospitals, cardiology offices, clinics, cardiac rehab centers and local communities.

    Seite 2 von 4




    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials - Seite 2 Grant Funding Provided by Cytokinetics to Each Organization to Help Increase Clinical Trial Engagement Among Historically Underrepresented GroupsSOUTH SAN FRANCISCO, Calif., and ALBANY, Ga., and WASHINGTON, Feb. 28, 2024 (GLOBE NEWSWIRE) - …

    Schreibe Deinen Kommentar

    Disclaimer